Literature DB >> 32876972

Ovarian cancer derived PKR1 positive exosomes promote angiogenesis by promoting migration and tube formation in vitro.

XiaoYan Zhang1, YouMing Sheng2, BingWei Li1, Qin Wang2, XueTing Liu1, JianQun Han2.   

Abstract

Cancer cell derived exosomes play important roles in cancer progression and modulation of the tumour microenvironment. This study aims to investigate the role of prokineticin receptor 1 (PKR1) positive exosomes on angiogenesis. In the present study, PKR1 expression in tumour samples from ovarian cancer patients were examined firstly. Then, two ovarian cancer cell lines, namely A2780 and HO-8910 cells, were used to isolate and obtain the PKR1 positive exosomes from the serum free medium. The function analysis of PKR1 positive exosomes on angiogenesis was conducted by cell proliferation and migration assay, tube formation analysis, and tumour volume assay. The results showed that PKR1 expression was down regulated in tumour samples of ovarian cancer patients compared with adjacent normal tissues. The intracellular expression of PKR1 could be detected in A2780 and HO-8910 cells. And, the isolated exosomes from the serum free medium were confirmed by transmission electron microscopic and NTA analysis, as well as the co-presence of PKR1 with exosome marker CD63. The function analysis of PKR1 positive exosomes on angiogenesis demonstrated the uptake of PKR1 positive exosomes by human umbilical vein endothelial cells through immunofluorescence staining. The angiogenesis assays in vitro indicated that PKR1 positive exosomes promoted migration and tube formation of HUVECs but not proliferation. The endogenous PKR1 was also verified to help to enhance migration and promote tube formation of vascular endothelial cells, which might involved in the phosphorylation of STAT3. Additionally, The tumour volume from exosomes treated A2780 tumour-bearing mice was significantly increased compared with the control group, accompanied with the induced PKR1 expression and phosphorylation of STAT3 level. SIGNIFICANCE OF THE STUDY: This study proved the important role of PKR1 positive exosomes released from ovarian cancer cells on promoting angiogenesis. The data indicated that PKR1 derived from ovarian cancer cells could act as an important tumour associated antigen and biomolecular factor for cellular communication in tumour microenvironment.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  PKR1; PROK1; angiogenesis; exosomes; ovarian cancer

Mesh:

Substances:

Year:  2020        PMID: 32876972     DOI: 10.1002/cbf.3583

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  13 in total

Review 1.  Emerging role of exosomes in cancer progression and tumor microenvironment remodeling.

Authors:  Mahshid Deldar Abad Paskeh; Maliheh Entezari; Sepideh Mirzaei; Amirhossein Zabolian; Hossein Saleki; Mohamad Javad Naghdi; Sina Sabet; Mohammad Amin Khoshbakht; Mehrdad Hashemi; Kiavash Hushmandi; Gautam Sethi; Ali Zarrabi; Alan Prem Kumar; Shing Cheng Tan; Marios Papadakis; Athanasios Alexiou; Md Asiful Islam; Ebrahim Mostafavi; Milad Ashrafizadeh
Journal:  J Hematol Oncol       Date:  2022-06-28       Impact factor: 23.168

2.  miR-106a-5p carried by tumor-derived extracellular vesicles promotes the invasion and metastasis of ovarian cancer by targeting KLF6.

Authors:  Yunyun Zheng; Kang Zhu; Guihu Wang
Journal:  Clin Exp Metastasis       Date:  2022-04-21       Impact factor: 4.510

3.  BMSC-Derived Exosomal miR-29a Promotes Angiogenesis and Osteogenesis.

Authors:  Guo-Dong Lu; Peng Cheng; Ting Liu; Zhong Wang
Journal:  Front Cell Dev Biol       Date:  2020-12-09

Review 4.  Exosomes in the Tumor Microenvironment: From Biology to Clinical Applications.

Authors:  Vitor Rodrigues da Costa; Rodrigo Pinheiro Araldi; Hugo Vigerelli; Fernanda D'Ámelio; Thais Biude Mendes; Vivian Gonzaga; Bruna Policíquio; Gabriel Avelar Colozza-Gama; Cristiane Wenceslau Valverde; Irina Kerkis
Journal:  Cells       Date:  2021-10-01       Impact factor: 6.600

Review 5.  The roles of exosomal immune checkpoint proteins in tumors.

Authors:  Cheng Xing; Heng Li; Rui-Juan Li; Le Yin; Hui-Fang Zhang; Zi-Neng Huang; Zhao Cheng; Ji Li; Zhi-Hua Wang; Hong-Ling Peng
Journal:  Mil Med Res       Date:  2021-11-08

Review 6.  Regenerative therapy by using mesenchymal stem cells-derived exosomes in COVID-19 treatment. The potential role and underlying mechanisms.

Authors:  Najmeh Kaffash Farkhad; Ali Mahmoudi; Elahe Mahdipour
Journal:  Regen Ther       Date:  2022-03-22       Impact factor: 3.419

7.  Hepatoblastoma: Derived Exosomal LncRNA NEAT1 Induces BMSCs Differentiation into Tumor-Supporting Myofibroblasts via Modulating the miR-132/MMP9 Axis.

Authors:  Yu Hu; Hongyan Zai; Wei Jiang; Zhenglin Ou; Yuanbing Yao; Qin Zhu
Journal:  J Oncol       Date:  2022-03-08       Impact factor: 4.375

8.  Exosomal miR-543 Inhibits the Proliferation of Ovarian Cancer by Targeting IGF2.

Authors:  Shupei Zhang; Diling Pan; Shaoyu Zhang; Qiumei Wu; Lan Zhen; Shihuang Liu; Jingjing Chen; Rong Lin; Qiuhua Hong; Xiangqin Zheng; Huan Yi
Journal:  J Immunol Res       Date:  2022-03-29       Impact factor: 4.818

9.  Exosomes from cervical cancer cells facilitate pro-angiogenic endothelial reconditioning through transfer of Hedgehog-GLI signaling components.

Authors:  Anjali Bhat; Joni Yadav; Kulbhushan Thakur; Nikita Aggarwal; Tanya Tripathi; Arun Chhokar; Tejveer Singh; Mohit Jadli; Alok Chandra Bharti
Journal:  Cancer Cell Int       Date:  2021-06-24       Impact factor: 5.722

Review 10.  Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion.

Authors:  Wanjia Tian; Ningjing Lei; Junying Zhou; Mengyu Chen; Ruixia Guo; Bo Qin; Yong Li; Lei Chang
Journal:  Cell Death Dis       Date:  2022-01-18       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.